Additive cytotoxic effect of bortezomib in combination with anti-CD20 or anti-CD52 monoclonal antibodies on chronic lymphocytic leukemia cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples